157 related articles for article (PubMed ID: 22447814)
1. Combined treatment with GH and anastrozole in a pubertal boy with Cushing's disease and postsurgical GH deficiency.
Boronat M; Marrero D; López-Plasencia Y; Nóvoa Y; García-Delgado Y; Nóvoa FJ
Eur J Endocrinol; 2012 Jun; 166(6):1101-5. PubMed ID: 22447814
[TBL] [Abstract][Full Text] [Related]
2. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.
Mauras N; Gonzalez de Pijem L; Hsiang HY; Desrosiers P; Rapaport R; Schwartz ID; Klein KO; Singh RJ; Miyamoto A; Bishop K
J Clin Endocrinol Metab; 2008 Mar; 93(3):823-31. PubMed ID: 18165285
[TBL] [Abstract][Full Text] [Related]
3. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
Neely EK; Kumar RB; Payne SL; Ranadive SA; Suchet DI
J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
[TBL] [Abstract][Full Text] [Related]
4. Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature.
Mauras N; Ross JL; Gagliardi P; Yu YM; Hossain J; Permuy J; Damaso L; Merinbaum D; Singh RJ; Gaete X; Mericq V
J Clin Endocrinol Metab; 2016 Dec; 101(12):4984-4993. PubMed ID: 27710241
[TBL] [Abstract][Full Text] [Related]
5. Letrozole as a booster therapy in growth hormone deficiency.
Kumar KV; Jayaraman M; Verma A; Modi KD
Indian Pediatr; 2009 Jul; 46(7):625-7. PubMed ID: 19638662
[TBL] [Abstract][Full Text] [Related]
6. Marked increase of final height by long-term aromatase inhibition in a boy with idiopathic short stature.
Krebs A; Moske-Eick O; Doerfer J; Roemer-Pergher C; van der Werf-Grohmann N; Schwab KO
J Pediatr Endocrinol Metab; 2012; 25(5-6):581-5. PubMed ID: 22876562
[TBL] [Abstract][Full Text] [Related]
7. Letrozole significantly improves growth potential in a pubertal boy with growth hormone deficiency.
Zhou P; Shah B; Prasad K; David R
Pediatrics; 2005 Feb; 115(2):e245-8. PubMed ID: 15653791
[TBL] [Abstract][Full Text] [Related]
8. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review.
Shams K; Cameo T; Fennoy I; Hassoun AA; Lerner SE; Aranoff GS; Sopher AB; Yang C; McMahon DJ; Oberfield SE
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):725-30. PubMed ID: 24756052
[TBL] [Abstract][Full Text] [Related]
9. Growth in disorders of adrenal hyperfunction.
Savage MO; Scommegna S; Carroll PV; Ho JT; Monson JP; Besser GM; Grossman AB
Horm Res; 2002; 58 Suppl 1():39-43. PubMed ID: 12373013
[TBL] [Abstract][Full Text] [Related]
10. Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study.
Papadimitriou DT; Dermitzaki E; Papagianni M; Papaioannou G; Papaevangelou V; Papadimitriou A
J Endocrinol Invest; 2016 Apr; 39(4):439-46. PubMed ID: 26507391
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
Hero M; Norjavaara E; Dunkel L
J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
[TBL] [Abstract][Full Text] [Related]
12. When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue.
Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Katsumata N; Tachibana K; Nose O; Hibi I
Acta Paediatr Suppl; 1999 Feb; 88(428):85-8. PubMed ID: 10102060
[TBL] [Abstract][Full Text] [Related]
13. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
Colmenares A; González L; Gunczler P; Lanes R
J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
[TBL] [Abstract][Full Text] [Related]
14. Use of growth hormone and gonadotropin releasing hormone agonist in addition to L-thyroxine to attain normal adult height in two patients with severe Hashimoto's thyroiditis.
Quintos JB; Salas M
J Pediatr Endocrinol Metab; 2005 May; 18(5):515-21. PubMed ID: 15921183
[TBL] [Abstract][Full Text] [Related]
15. Growth Hormone With Aromatase Inhibitor May Improve Height in CYP11B1 Congenital Adrenal Hyperplasia.
Hawton K; Walton-Betancourth S; Rumsby G; Raine J; Dattani M
Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28126912
[TBL] [Abstract][Full Text] [Related]
16. Delayed closure of epiphyseal cartilages induced by the aromatase inhibitor anastrozole. Would it help short children grow up?
Faglia G; Arosio M; Porretti S
J Endocrinol Invest; 2000 Dec; 23(11):721-3. PubMed ID: 11194703
[TBL] [Abstract][Full Text] [Related]
17. Earlier initiation of GH therapy does not influence adult height but enables earlier start of pubertal induction in children with multiple pituitary hormone deficiency.
Kawai M; Momoi T; Mamada M; Yorifuji T; Nakahata T
Clin Endocrinol (Oxf); 2004 May; 60(5):608-12. PubMed ID: 15104564
[TBL] [Abstract][Full Text] [Related]
18. An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys.
Mauras N; Welch S; Rini A; Klein KO
J Pediatr Endocrinol Metab; 2004 Dec; 17(12):1597-606. PubMed ID: 15645693
[TBL] [Abstract][Full Text] [Related]
19. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
Hero M; Wickman S; Dunkel L
Clin Endocrinol (Oxf); 2006 May; 64(5):510-3. PubMed ID: 16649968
[TBL] [Abstract][Full Text] [Related]
20. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
Reiter EO; Lindberg A; Ranke MB; Price DA; Albertsson-Wikland K; Cowell CT; Bakker B
Horm Res; 2003; 60(Suppl 1):68-73. PubMed ID: 12955021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]